Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.
Latest website image capture
Clouds background image

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the study record page. This does not imply changes to the study content.
    Difference
    0.1%
    Check dated 2026-06-05T12:26:19.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new version of the page content. The new version supersedes the previous revision.
    Difference
    0.1%
    Check dated 2026-05-15T05:52:57.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Updates the displayed ClinicalTrials.gov page revision/version from **v3.5.2** to **v3.5.3** without changing the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:56:51.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:26.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:45:07.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:54.000Z thumbnail image

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist

Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.